Novavax Inc (NASDAQ:NVAX)

7.20
BATS BZX Real-Time Price
As of 10:27am ET
 -0.015 / -0.21%
Today’s Change
5.61
Today|||52-Week Range
76.77
-30.01%
Year-to-Date
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$590.3M

Company Description

Novavax, Inc. Is a biotechnology company, which engages in the discovery, development, and commercialization of recombinant vaccines. The company was founded in 1987 and is headquartered in Gaithersburg, MD.

Contact Information

Novavax, Inc.
21 Firstfield Road
Gaithersburg Maryland 20878
P:(240) 268-2000
Investor Relations:

Employees

Shareholders

Other institutional39.69%
Mutual fund holders30.16%
Individual stakeholders0.30%

Top Executives

John C.s JacobsPresident, Chief Executive Officer & Director
Richard CrowleyChief Operating Officer & Executive Vice President
James Patrick KellyChief Financial Officer, Treasurer & Executive VP
Gale E. SmithChief Scientist & Senior Vice President-Discovery
Biegie LeeChief Information Officer & Senior Vice President